SCHEDULE 13G/A: Avidity Partners Discloses 4.2% Passive Stake in Perspective Therapeutics
Beneficial Ownership Disclosure
Avidity Partners Management LP and affiliated entities, along with Michael Gregory, have disclosed a passive beneficial ownership of 4.2% in Perspective Therapeutics, Inc., holding 2,841,024 shares as of December 31, 2024.
Summary
- Avidity Partners Management LP, Avidity Partners Management (GP) LLC, Avidity Capital Partners Fund (GP) LP, Avidity Capital Partners (GP) LLC, and Michael Gregory collectively reported beneficial ownership of 2,841,024 shares of Perspective Therapeutics, Inc. Common Stock.
- This aggregate amount represents 4.2% of the Issuer's Common Stock outstanding.
- The percentage of ownership is based on 67,587,540 shares of Common Stock outstanding as of November 7, 2024, as reported in the Issuer's Form 10-Q filed on November 12, 2024.
- The reporting persons hold shared voting power and shared dispositive power over all 2,841,024 shares.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating a passive investment intent and that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing disclosing beneficial ownership, with no explicit positive or negative financial or operational information.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- The disclosure of a passive institutional stake may provide a minor positive signal of investor confidence, but given it's below 5% and a routine amendment, the direct impact on stakeholders is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 2024-11-07 | Date as of which 67,587,540 shares of Common Stock were outstanding for Perspective Therapeutics, Inc. |
| 2024-11-12 | Date Perspective Therapeutics, Inc. filed its Form 10-Q, reporting the outstanding shares. |
| 2024-12-31 | Date of event which requires the filing of this Schedule 13G Amendment No. 1 (ownership snapshot date). |
| 2025-02-14 | Filing date of the Schedule 13G Amendment No. 1. |
Keywords
Perspective Therapeutics, Avidity Partners Management, SEC filing, Schedule 13G, beneficial ownership, common stock, passive investment, institutional investor, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.